Publications by authors named "Sander M Botter"

Claim this Profile
N
Neuro-Urology and Biobanking: An Integrated Approach for Advancing Research and Improving Patient Care.
Sander M Botter, Thomas M Kessler

Int J Mol Sci· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intra-articular injection of triamcinolone acetonide sustains macrophage levels and aggravates osteophytosis during degenerative joint disease in mice.
Mauricio N Ferrao Blanco, Yvonne M Bastiaansen Jenniskens, Nicole Kops, Athina Chavli, Roberto Narcisi, Sander M Botter

Br J Pharmacol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of the activin receptor signaling pathway: A novel intervention against osteosarcoma.
Daniela Meier, Andreas Lodberg, Ana Gvozdenovic, Giovanni Pellegrini, Olga Neklyudova, Sander M Botter

Cancer Med· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TASCI-transcutaneous tibial nerve stimulation in patients with acute spinal cord injury to prevent neurogenic detrusor overactivity: protocol for a nationwide, randomised, sham-controlled, double-blind clinical trial.
Veronika Birkhäuser, Martina D Liechti, Collene E Anderson, Lucas M Bachmann, Sarah Baumann, Sander M Botter

BMJ Open· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The miR-143/145 Cluster, a Novel Diagnostic Biomarker in Chondrosarcoma, Acts as a Tumor Suppressor and Directly Inhibits Fascin-1.
Joaquin Urdinez, Aleksandar Boro, Alekhya Mazumdar, Matthias Je Arlt, Roman Muff, Sander M Botter

J Bone Miner Res· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short postsurgical antibiotic therapy for spinal infections: protocol of prospective, randomized, unblinded, noninferiority trials (SASI trials).
Michael Betz, Ilker Uçkay, Regula Schüpbach, Tanja Gröber, Sander M Botter

Trials· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of F8-TNF-α in Models of Early and Progressive Metastatic Osteosarcoma.
Bernhard Robl, Sander Martijn Botter, Aleksandar Boro, Daniela Meier, Dario Neri

Transl Oncol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Foscan and foslip based photodynamic therapy in osteosarcoma in vitro and in intratibial mouse models.
Daniela Meier, Sander M Botter, Carmen Campanile, Bernhard Robl, Susanna Gräfe

Int J Cancer· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Altered CXCL12 expression reveals a dual role of CXCR4 in osteosarcoma primary tumor growth and metastasis.
Olga Neklyudova, Matthias J E Arlt, Patrick Brennecke, Marcus Thelen, Ana Gvozdenovic, Sander M Botter

J Cancer Res Clin Oncol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Explant culture of sarcoma patients' tissue.
Roman Muff, Sander M Botter, Knut Husmann, Joelle Tchinda, Philomina Selvam

Lab Invest· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of intraarterial and intravenous cisplatin chemotherapy in the treatment of metastatic osteosarcoma using an orthotopic xenograft mouse model.
Bernhard Robl, Sander Martijn Botter, Giovanni Pellegrini, Olga Neklyudova, Bruno Fuchs

J Exp Clin Cancer Res· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy.
Bernhard Robl, Chantal Pauli, Sander Martijn Botter, Beata Bode-Lesniewska, Bruno Fuchs

BMC Cancer· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell-autonomous progeroid changes in conditional mouse models for repair endonuclease XPG deficiency.
Sander Barnhoorn, Lieneke M Uittenboogaard, Dick Jaarsma, Wilbert P Vermeij, Maria Tresini, Sander M Botter

PLoS Genet· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent advances in osteosarcoma.
Sander M Botter, Dario Neri, Bruno Fuchs

Curr Opin Pharmacol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytotoxic efficacy of photodynamic therapy in osteosarcoma cells in vitro.
Daniela Meier, Carmen Campanile, Sander M Botter, Walter Born, Bruno Fuchs

J Vis Exp· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genes regulated in metastatic osteosarcoma: evaluation by microarray analysis in four human and two mouse cell line systems.
Roman Muff, Ram Mohan Ram Kumar, Sander M Botter, Walter Born, Bruno Fuchs

Sarcoma· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone fragility and decline in stem cells in prematurely aging DNA repair deficient trichothiodystrophy mice.
Karin E M Diderich, Claudia Nicolaije, Matthias Priemel, Jan H Waarsing, Judd S Day, Sander M Botter

Age (Dordr)· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of osteoarthritis in a mouse model of the progeroid human DNA repair syndrome trichothiodystrophy.
Sander M Botter, Michel Zar, Gerjo J V M van Osch, Harry van Steeg, Martijn E T Dollé

Age (Dordr)· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Osteoarthritis induction leads to early and temporal subchondral plate porosity in the tibial plateau of mice: an in vivo microfocal computed tomography study.
Sander M Botter, Gerjo J V M van Osch, Stefan Clockaerts, Jan H Waarsing, Harrie Weinans

Arthritis Rheum· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RGD-modified anti-CD3 antibodies redirect cytolytic capacity of cytotoxic T lymphocytes toward alphavbeta3-expressing endothelial cells.
Astrid J Schraa, Robbert J Kok, Sander M Botter, Sebo Withoff, Dirk K F Meijer

Int J Cancer· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis